Table 4.

Mycological tests and clinical characteristics of patients with at least one result suggestive of invasive pulmonary Aspergillosis

Patient	A. fumigatus detection in respiratory samples				Galactomannan (positive/tested)		AspICU – Putative Criteria [34]			ECMO
	Sample numbera	CMg	qPCR (Cq)	Culture (Positive/Tested)	BAL > 1.0	Serum > 0.5	Radiology	Clinical	Host
563	S28	Positive	31	Positive			Yes	Yes	Yes – steroid	No
	Other	ND	ND	3/6	0/1	0/0
613	S18	Negative	> 40	Negative			Yes	Yes	No	No
	Other	ND	ND	2/2	1/1	0/0
677	S63	Negative	> 40	Negative			Yes	Yes	Yes – steroid	No
	S54	Negative	> 40	Negative
	S52	Negative	> 40	Negative
	Other	ND	ND	0/8	2/2	0/5
740	S59	Negative	> 40	Negative			Yes	Yes	Yes – leukaemia on chemotherapy	No
	S30	Negative	> 40	Negative
	Other	ND	ND	0/16	1/4	1/2
1033	S8	Positive	33	Positive			Yes	Yes	Yes – steroid	Yes
	Other	ND	ND	0/0	1/1	1/1
1346	S56	Positive	32	Positive			Yes	Yes	Yes – steroid, anakinra	Yes
	Other	ND	ND	0/3	1/1	0/2
1440	S33	Negative	> 40	Negative			Yes	Yes	Yes – steroid, anakinra	Yes
	Other	ND	ND	0/4	1/2	0/1
1457	S65	Negative	> 40	Negative			Yes	Yes	Yes – steroid	Yes
	S64	Negative	> 40	Negative
	Other	ND	ND	0/9	2/2	0/2
1538	S55	Positive	31	Negative			Yes	Yes	Yes – lymphoma on chemotherapy	No
	Other	ND	ND	4/5	0/0	1/1

ND = not done

^aOther sample represents samples from the nine patients, retrieved after an ITU episode but were outside the CMg period and were not processed with CMg